BioHarvest Appoints VP with $30M CRO Contract Track Record for CDMO Division
BHST•BioHarvest Sciences appointed Nedira Salzman-Frenkel as Vice President of Business Development for its CDMO division, overseeing sourcing and managing contracts in pharmaceutical, nutraceutical and cosmetic sectors. She brings over a decade of biotech leadership—including securing $30 million in CRO contracts—and will drive revenue targets ahead of a new facility launch.
1. New Business Development Leadership
BioHarvest Sciences announced the hiring of Nedira Salzman-Frenkel as Vice President of Business Development for its CDMO division. In her new role, she will lead efforts to secure and manage development and manufacturing partnerships across pharmaceutical, nutraceutical and cosmetic markets.
2. Extensive Biotech and CRO Experience
Salzman-Frenkel brings over ten years of industry experience, having secured approximately $30 million in CRO contracts while leading business development for a global pharmaceutical and contract research organization. Her background includes licensing deals with top-tier pharma firms, operational scaling and building cross-functional teams.
3. Strategic Impact and Growth Outlook
Her appointment aligns with BioHarvest’s aim to meet aggressive revenue targets and support the launch of a new CDMO facility next year. Collaboration with executive leadership will focus on expanding long-term customer partnerships and commercial opportunities across multiple industries.
Related News
US natgas dips to six-week low on milder weather outlook, lower LNG exports
Lockheed Martin wins $850 million US Navy contract modification for Trident II D5LE2 program
